Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-25

Clinical Trial Update: Comparing 3 vs 6 Cycles of Platinum-based Chemotherapy Prior to Maintenance Avelumab in Advanced Urothelial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is comparing 3 versus 6 cycles of platinum-based chemotherapy before maintenance avelumab in advanced bladder cancer and is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avelumab (avelumab)

Snippet

Sponsor: Queen Mary University of London | Conditions: Urinary Bladder Neoplasms | Phase 2 | Status: RECRUITING